Picture of DOTA (5 mg)

DOTA (5 mg)

Cation complexation agent

Product No.: DOTA-95-0005

DOTA

Product No.：DOTA-95
CAS No.：60239-18-1


Product Name:	DOTA-95
Synonyms:	,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid; 1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid; NSC 681107; Tetraxetan
CAS No.:	60239-18-1
Molecular Formula:	C₁₆H₂₈N₄O₈•H₂O
Molecular Weight:	404.42
Application:	Cation complexation agent
Presentation:	Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.

Note

Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)It shall be only used by qualified personnel and only for research.

Order Number

DOTA-95-0010x 10mg per vial
DOTA-95-0020x 20mg per vial
- note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial
- *Customized dispensing is available

Literature

Li W.P. et al. DOTA-D-Tyr1-Octreotate: A Somatostatin Analogue for Labeling with Metal and Halogen Radionuclides for Cancer Imaging and Therapy. Bioconjugate Chem. 2002, 13, 721-728.
Traub T. et al. 111In-DOTA-Lanreotide Scintigraphy in Patients with Tumors of the Lung. J. Nucl. Med. 2001, 42, 1309-1315.